A clinical trial update dated September 29, 2026 reports that a new study involving insulin lispro is recruiting participants. The study, titled "A Study of LY4057996 in Healthy Participants and Participants With Type 1 and Type 2 Diabetes," is registered under identifier NCT06945406. It is listed as a Phase 1 trial, the earliest stage of clinical testing. According to the registry, the trial status is currently RECRUITING, meaning enrollment is open but data collection has not concluded. The study is designed to include healthy participants as well as participants diagnosed with type 1 and type 2 diabetes. No results, efficacy outcomes, or safety findings have been posted for this trial at this time. The information available reflects only the trial's design, phase, and recruitment status as recorded on ClinicalTrials.gov. Further updates may be issued as the trial progresses through subsequent stages. Readers interested in background on insulin lispro, including its approved uses and regulatory status, can consult the compound overview for additional context.
Phase 1 Trial Involving Insulin Lispro Begins Recruiting Participants
See the full insulin lispro overview
Source: https://clinicaltrials.gov/study/NCT06945406